Search results
...Announces Long-term Efficacy and Safety Data from a Phase IIIClinical Trial of Stapokibart for...
The Pendulum· 1 day agoKeymed Biosciences Inc. (HKEX: 02162) today announced the long-term efficacy and safety data of a Phase III clinical trial of stapokibart injection in patients ...
Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You?
Motley Fool via Yahoo Finance· 1 hour agoIn fact, that might take a few years, so this is a fairly risky bet to take as of right now. Its...
The 3 Most Undervalued Biotech Stocks to Buy in June 2024
InvestorPlace· 2 hours agoUndervalued biotech stocks can offer some of the most explosive opportunities. Many times, biotech...
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 17 hours agoMelanoma patients who received monthly mRNA vaccines and Merck’s Keytruda immunotherapy had lower...
Lexicon selects Medidata to advance Phase IIb non-opioid pain drug trial
Clinical Trials Arena via Yahoo Finance· 5 days agoLexicon Pharmaceuticals has chosen clinical trial solutions provider Medidata to help advance the...
Here's Why You Should Retain Glaukos (GKOS) Stock for Now
Zacks via Yahoo Finance· 18 hours agoGlaukos Corporation GKOS is well-poised for growth on the back of favorable clinical trial results...
Cincinnati's new gene therapy center to boost clinical trials for children
Local 12 Cincinnati· 18 hours agoA center that helps provide cutting-edge therapies from blood cancers to birth defects, expanded....
Why Microbot Medical Stock Is Up - Microbot Medical (NASDAQ:MBOT)
Benzinga· 20 hours agoMicrobot Medical Inc. MBOT shares are trading higher Monday after the company announced that it has...
L Theanine and Magnesium for Anxiety Management
Verywell Health via Yahoo News· 19 hours agoA review of nine published articles showed that taking 200 to 400 mg of L-theanine a day can help reduce anxiety in people exposed to stressful...
FDA panel to review psychedelic drug MDMA for first time
AOL· 56 minutes agoA panel of advisers to the U.S. Food and Drug Administration will meet on Tuesday to discuss a therapy based on the psychedelic drug MDMA for patients with post-traumatic stress disorder (PTSD ...
